MENU
+Compare
CRDL
Stock ticker: NASDAQ
AS OF
Sep 8, 12:21 PM (EDT)
Price
$1.07
Change
-$0.02 (-1.83%)
Capitalization
93.33M

CRDL Cardiol Therapeutics Forecast, Technical & Fundamental Analysis

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases... Show more

CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRDL with price predictions
Sep 05, 2025

CRDL sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for CRDL moved above the 200-day moving average on July 31, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CRDL's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDL advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRDL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CRDL as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CRDL turned negative on August 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

CRDL moved below its 50-day moving average on August 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CRDL crossed bearishly below the 50-day moving average on August 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRDL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.661) is normal, around the industry mean (16.653). P/E Ratio (0.000) is within average values for comparable stocks, (74.307). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.902). CRDL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.000) is also within normal values, averaging (42.886).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRDL is expected to report earnings to rise 23.27% to -8 cents per share on November 18

Cardiol Therapeutics CRDL Stock Earnings Reports
Q3'25
Est.
$-0.09
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.05
The last earnings report on August 19 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 82.97K shares outstanding, the current market capitalization sits at 93.33M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2265 Upper Middle Road East
Phone
+1 289 910-0850
Employees
22
Web
https://www.cardiolrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGGEF15.141.08
+7.68%
Sage Group plc (The)
UMGP0.02N/A
+1.87%
Universal Media Group, Inc.
VGPBF107.85N/A
N/A
VGP SA
HGRVF7.33N/A
N/A
Hargreaves Services Plc
NWVCF0.25-0.01
-5.33%
EnWave Corp.

CRDL and Stocks

Correlation & Price change

A.I.dvisor tells us that CRDL and ACB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
-1.80%
ACB - CRDL
30%
Poorly correlated
+1.66%
EOLS - CRDL
30%
Poorly correlated
+2.00%
LNTH - CRDL
29%
Poorly correlated
+1.73%
SCYX - CRDL
26%
Poorly correlated
+2.43%
TLRY - CRDL
24%
Poorly correlated
+3.48%
More

Groups containing CRDL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
-1.80%
Pharmaceuticals: Generic
industry (222 stocks)
-5%
Poorly correlated
+2.50%